POSSIBLE SEROTONERGIC AND DOPAMINERGIC MEDIATION OF THE N-ETHYL-3,4-METHYLENEDIOXYAMPHETAMINE DISCRIMINATIVE STIMULUS

被引:7
作者
BOJA, JW [1 ]
SCHECHTER, MD [1 ]
机构
[1] NORTHEASTERN OHIO UNIV,COLL MED,DEPT PHARMACOL,ROOTSTOWN,OH 44272
关键词
MDE (N-ETHYL-3,4-METHYLENEDIOXYAMPHETAMINE); MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE); 5-HT; (5-HYDROXYTRYPTAMINE; SEROTONIN); DOPAMINE; P-CHLOROPHENYLALANINE; DRUG DISCRIMINATION;
D O I
10.1016/0014-2999(91)90277-W
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Eight male rats previously trained to discriminate 2.0 mg/kg N-ethyl-3,4-methylenedioxyamphetamine (MDE) from its vehicle in a two-lever, food motivated task were utilized to characterize the stimulus properties of MDE. The 5-HT receptor agonists 1-(m-trifluoromethylphenyl)piperazine (TFMPP), quipazine and 6-methoxy-1,2,3,4 tetrahydro-beta-carboline were able to generalize to the stimulus produced by MDE. However, the 5-HT receptor agonists m-chlorophenylpiperazine (mCPP), buspirone and norfenfluramine, the dopamine receptor agonist amphetamine, as well as the acetylcholine receptor agonist arecoline did not completely generalize. In addition, the simultaneous administration of norfenfluramine and amphetamine generalized to MDE. Pretreatment with the serotonin receptor antagonists cinanserin and metergoline or the dopamine receptor antagonist haloperidol failed to completely inhibit the discriminative stimulus produced by MDE. Multiple p-chlorophenylalanine (PCPA) pretreatments significantly reduced MDE discrimination, whereas vehicle discrimination was unaffected. Five days following cessation of PCPA pretreatment, MDE discrimination returned to criterion levels and remained at that level. These results suggest that the stimulus produced by MDE involve a complex interaction of various neurotransmitters, with both serotonergic and dopaminergic components.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 33 条
[21]   BEHAVIORAL-EFFECTS OF (+/-) 3,4-METHYLENEDIOXYAMPHETAMINE (MDA) AND (+/-) 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN THE PIGEON - INTERACTIONS WITH NORADRENERGIC AND SEROTONERGIC SYSTEMS [J].
NADER, MA ;
HOFFMANN, SM ;
BARRETT, JE .
PSYCHOPHARMACOLOGY, 1989, 98 (02) :183-188
[22]  
OBERLENDER R, 1988, PSYCHOPHARMACOLOGY, V95, P71
[23]   5-HYDROXYTRYPTAMINE RECEPTOR SUBTYPES [J].
PEROUTKA, SJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1988, 11 :45-60
[24]   SEROTONIN-RELEASING EFFECTS OF SUBSTITUTED PIPERAZINES INVITRO [J].
PETTIBONE, DJ ;
WILLIAMS, M .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (09) :1531-1535
[25]   DOPAMINERGIC ACTIVITY OF QUIPAZINE [J].
SCHECHTER, MD ;
CONCANNON, JT .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1982, 17 (03) :393-397
[26]   DISCRIMINATIVE PROFILE OF MDMA [J].
SCHECHTER, MD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (06) :1533-1537
[27]   MDMA AS A DISCRIMINATIVE STIMULUS - ISOMERIC COMPARISONS [J].
SCHECHTER, MD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 27 (01) :41-44
[28]  
SCHECHTER MD, 1988, PHARM BIOCH BEHAV, V31
[30]   6-METHOXY-1,2,3,4-TETRAHYDRO-BETA-CARBOLINE - A SPECIFIC MONOAMINE OXIDASE-A INHIBITOR IN CF-1 MOUSE-BRAIN [J].
SPARKS, DL ;
BUCKHOLTZ, NS .
NEUROSCIENCE LETTERS, 1980, 20 (01) :73-78